➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
Medtronic
Baxter

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Heather Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HEATHER, and what generic and branded alternatives to HEATHER drugs are available?

HEATHER has twenty-six approved drugs.



Summary for Heather
US Patents:0
Tradenames:18
Ingredients:18
NDAs:26
Patent Litigation for Heather: See patent lawsuits for Heather

Drugs and US Patents for Heather

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heather PREDNISONE prednisone TABLET;ORAL 085543-001 Approved Prior to Jan 1, 1982 DISCN No No   Try Before You Buy   Try Before You Buy
Heather DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 086798-001 Approved Prior to Jan 1, 1982 DISCN No No   Try Before You Buy   Try Before You Buy
Heather METHOCARBAMOL methocarbamol TABLET;ORAL 084924-001 Approved Prior to Jan 1, 1982 DISCN No No   Try Before You Buy   Try Before You Buy
Heather CORTISONE ACETATE cortisone acetate TABLET;ORAL 085736-001 Approved Prior to Jan 1, 1982 DISCN No No   Try Before You Buy   Try Before You Buy
Heather DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062463-001 Dec 7, 1983 DISCN No No   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Dow
Boehringer Ingelheim
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.